ArticleBJR artificial intelligence2026
Federated artificial intelligence monitoring service (FAMOS): an in silico feasibility study.
Article in BJR artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To evaluate feasibility of a federated AI monitoring service (FAMOS) for post-deployment surveillance of third-party AI applications used in chest X-ray (CXR) interpretation. Methods: FAMOS was deployed at 2 NHS Trusts using a federated architecture enabling local data processing while maintaining data governance compliance. De-identified CXRs from patients aged >18 years were retrospectively identified, along with relevant patient attributes (age, sex, inpatient status, image orientation, season, artefact). Chest X-rays were processed by 2 AI applications to simulate real-world deployment. FAMOS analyzed input data, AI inference values, and longitudinal human-AI agreement as proxy indicators of data, prediction, and behavioral drift. Input monitoring used image feature embeddings analyzed with principal component analysis and Hotelling's Results: Input monitoring identified a small proportion of outlier examinations, predominantly associated with modifiable image quality issues. Artificial intelligence inference values remained stable across most findings for both vendors, with limited drift events detected. Human-AI agreement patterns differed between sites, remaining stable at 1 site while increasing over time at another, suggesting evolving automation bias. Conclusions: Real-time, federated monitoring of deployed radiology AI systems is technically and operationally feasible within clinical environments. Multi-domain platform-based monitoring provides scalable, independent oversight and may function as an early-warning system supporting identification of emerging risks following deployment. Advances in knowledge: This study introduces a federated, multi-domain monitoring framework integrating sociotechnical indicators for continuous post-deployment surveillance of clinical radiology AI tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.